A study examining the relationship between sleep and vaccine acquired COVID-19 antibody titer

A study examining the relationship between sleep and vaccine acquired COVID-19 antibody titer - A study of sleep and COVID-19 antibody titer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045009

Enrollment

Registered

2021-07-30

Start date

2021-07-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, insomnia, shortage of sleep

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy adults less than 60 years of age at the start of observation scheduled for COVID-19 vaccination.

Exclusion criteria

Exclusion criteria: 1) Patients who cannot meet the selection criteria 2) Patients deemed inappropriate by the principal investigator 3) Patients who are abusing drugs at the start of observation 4) Patients suffering from a disease requiring drug therapy at the time of starting observation. 5) Vaccinated within one month of the start of the study 6) Has a clear history of COVID-19 (as evidenced by PCR test, etc.) 7) Satisfies the exclusion criteria for vaccination (previous allergy to vaccine, history of convulsions, possible allergy)

Design outcomes

Primary

Measure	Time frame
The relationship between objective and subjective sleep parameter and IgG antibody titer against COVID-19 spike protein and nucleotide protein two weeks after vaccination	—

Countries

Japan

Contacts

Public ContactIzuhara Muneto

National Institute of Mental Health, National Center of Neurology and Psychiatry Department of Clinical Laboratory

sdc.covid19.2021@gmail.com042-341-2711

Outcome results